EDGAR Filing Documents for 0001654954-17-004582

Form 8-K - Current report:

SEC Accession No. 0001654954-17-004582

Filing Date

2017-05-12

Accepted

2017-05-12 16:07:24

Documents

Period of Report

2017-05-08

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ndra_8k.htm	8-K	42204
2	CERTIFICATE OF AMENDMENT	ndra_ex31.htm	EX-3.1	11154
3	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION	ndra_ex32.htm	EX-3.2	33830
4	AMENDED AND RESTATED EMPLOYMENT AGREEMENT	ndra_ex101.htm	EX-10.1	37350
5	AMENDED AND RESTATED EMPLOYMENT AGREEMENT	ndra_ex102.htm	EX-10.2	35269
6	CONSULTING AGREEMENT	ndra_ex103.htm	EX-10.3	45067
7	IMAGE	img001.jpg	GRAPHIC	5671
	Complete submission text file	0001654954-17-004582.txt		214246

Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105

Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468

ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)